Physiological and pathological changes in glucose regulate brain akt and glycogen synthase kinase-3

被引:105
作者
Clodfelder-Miller, B
De Sarno, P
Zmijewska, AA
Song, L
Jope, RS
机构
[1] Univ Alabama Birmingham, Dept Psychiat, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA
关键词
D O I
10.1074/jbc.M508824200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin regulates the phosphorylation and activities of Akt and glycogen synthase kinase-3 ( GSK3) in peripheral tissues, but in the brain it is less clear how this signaling pathway is regulated in vivo and whether it is affected by diabetes. We found that Akt and GSK3 are sensitive to glucose, because fasting decreased and glucose administration increased by severalfold the phosphorylation of Akt and GSK3 in the cerebral cortex and hippocampus of non-diabetic mice. Brain Akt and GSK3 phosphorylation also increased after streptozotocin administration ( 3 days), which increased blood glucose and depleted blood insulin, indicating regulation by glucose availability even with deficient insulin. Changes in Akt and GSK3 phosphorylation and activities in epididymal fat were opposite to those of brain after streptozotocin treatment. Streptozotocin-induced hyperglycemia and increased brain Akt and GSK3 phosphorylation were reversed by lowering blood glucose with insulin administration. Long term hyperglycemia also increased brain Akt and GSK3 phosphorylation, both 4 weeks after streptozotocin and in db/db insulin-resistant mice. Thus, the Akt-GSK3 signaling pathway is regulated in mouse brain in vivo in response to physiological and pathological changes in insulin and glucose.
引用
收藏
页码:39723 / 39731
页数:9
相关论文
共 41 条
  • [1] The neural basis of functional brain imaging signals
    Attwell, D
    Iadecola, C
    [J]. TRENDS IN NEUROSCIENCES, 2002, 25 (12) : 621 - 625
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (falfa) rats
    Cline, GW
    Johnson, K
    Regittnig, W
    Perret, P
    Tozzo, E
    Xiao, L
    Damico, C
    Shulman, GI
    [J]. DIABETES, 2002, 51 (10) : 2903 - 2910
  • [4] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
    CROSS, DAE
    ALESSI, DR
    COHEN, P
    ANDJELKOVICH, M
    HEMMINGS, BA
    [J]. NATURE, 1995, 378 (6559) : 785 - 789
  • [5] Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
    Eldar-Finkelman, H
    Schreyer, SA
    Shinohara, MM
    LeBoeuf, RC
    Krebs, EG
    [J]. DIABETES, 1999, 48 (08) : 1662 - 1666
  • [6] Glycogen synthase kinase 3: an emerging therapeutic target
    Eldar-Finkelman, H
    [J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (03) : 126 - 132
  • [7] Cognition and synaptic plasticity in diabetes mellitus
    Gispen, WH
    Biessels, GJ
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (11) : 542 - 549
  • [8] The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
    Grimes, CA
    Jope, RS
    [J]. PROGRESS IN NEUROBIOLOGY, 2001, 65 (04) : 391 - 426
  • [9] Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats
    Henriksen, EJ
    Kinnick, TR
    Teachey, MK
    O'Keefe, MP
    Ring, D
    Johnson, KW
    Harrison, SD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (05): : E892 - E900
  • [10] Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease
    Ho, L
    Qin, WP
    Pompl, PN
    Xiang, ZM
    Wang, J
    Zhao, Z
    Peng, YZ
    Cambareri, G
    Rocher, A
    Mobbs, CV
    Hof, PR
    Pasinetti, GM
    [J]. FASEB JOURNAL, 2004, 18 (03) : 902 - +